PT96388A - Processo para a obtencao de um promotor artificial para a expressao de proteinas em levedura - Google Patents

Processo para a obtencao de um promotor artificial para a expressao de proteinas em levedura

Info

Publication number
PT96388A
PT96388A PT96388A PT9638890A PT96388A PT 96388 A PT96388 A PT 96388A PT 96388 A PT96388 A PT 96388A PT 9638890 A PT9638890 A PT 9638890A PT 96388 A PT96388 A PT 96388A
Authority
PT
Portugal
Prior art keywords
proteins
yeast
sequence
expression
obtaining
Prior art date
Application number
PT96388A
Other languages
English (en)
Other versions
PT96388B (pt
Inventor
Gerard Loison
Pascal Leplatois
Bernard Pessegue
David Shire
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT96388A publication Critical patent/PT96388A/pt
Publication of PT96388B publication Critical patent/PT96388B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12N9/0048—Uricase (1.7.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
    • C12Y107/03—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12Y107/03003—Factor-independent urate hydroxylase (1.7.3.3), i.e. uricase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PT96388A 1989-12-29 1990-12-28 Processo para a obtencao de um promotor artificial para a expressao de proteinas em levedura PT96388B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8917467A FR2656531B1 (fr) 1989-12-29 1989-12-29 Promoteur artificiel pour l'expression de proteines dans le levure.

Publications (2)

Publication Number Publication Date
PT96388A true PT96388A (pt) 1991-10-15
PT96388B PT96388B (pt) 1998-06-30

Family

ID=9389162

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96388A PT96388B (pt) 1989-12-29 1990-12-28 Processo para a obtencao de um promotor artificial para a expressao de proteinas em levedura

Country Status (14)

Country Link
EP (1) EP0435776B1 (pt)
JP (1) JP2723358B2 (pt)
AT (1) ATE127845T1 (pt)
BR (1) BR1100340A (pt)
CA (1) CA2048676C (pt)
DE (1) DE69022380T2 (pt)
DK (1) DK0435776T3 (pt)
ES (1) ES2080816T3 (pt)
FR (1) FR2656531B1 (pt)
GR (1) GR3018220T3 (pt)
IE (1) IE71208B1 (pt)
LV (1) LV11748B (pt)
PT (1) PT96388B (pt)
WO (1) WO1991009956A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006196A1 (en) * 1990-09-28 1992-04-16 Cetus Oncology Corporation Gro genes, proteins, and uses thereof
US6110707A (en) * 1996-01-19 2000-08-29 Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
KR20220064647A (ko) 2020-11-12 2022-05-19 에스케이이노베이션 주식회사 내산성 효모 유전자 기반 합성 프로모터

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529675A (fr) * 1967-03-29 1968-06-21 Applic Biochimiques Soc Et Urate oxydase à haute activité et sa préparation
EP0164556B1 (en) * 1984-05-11 1994-03-02 Chiron Corporation Enhanced yeast transcription employing hybrid promoter region constructs
EP0174585A3 (en) * 1984-09-14 1987-12-23 Miles Laboratories, Inc. Promoters and the use thereof in the expression of unfused procaryotic or eucaryotic proteins in yeast
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
DE3888561T2 (de) * 1987-03-23 1994-09-01 Zymogenetics Inc Hohe Proteinsyntheserate in Hefe.
JPS6451089A (en) * 1987-08-21 1989-02-27 Yamasa Shoyu Kk Polynucleotide fragment

Also Published As

Publication number Publication date
CA2048676A1 (en) 1991-06-30
IE904706A1 (en) 1991-07-17
LV11748A (lv) 1997-04-20
PT96388B (pt) 1998-06-30
WO1991009956A1 (fr) 1991-07-11
DE69022380T2 (de) 1996-03-28
DK0435776T3 (da) 1996-02-05
EP0435776A1 (fr) 1991-07-03
ATE127845T1 (de) 1995-09-15
EP0435776B1 (fr) 1995-09-13
GR3018220T3 (en) 1996-02-29
FR2656531B1 (fr) 1992-04-24
DE69022380D1 (de) 1995-10-19
JPH07507439A (ja) 1995-08-24
IE71208B1 (en) 1997-02-12
CA2048676C (en) 2000-04-04
JP2723358B2 (ja) 1998-03-09
FR2656531A1 (fr) 1991-07-05
LV11748B (en) 1997-08-20
BR1100340A (pt) 2000-03-14
ES2080816T3 (es) 1996-02-16

Similar Documents

Publication Publication Date Title
DE3584149D1 (de) Verfahren zur herstellung von alkohol.
DK221589D0 (da) Fremgangsmaade til at udtrykke ikke-gaerprotein i en gaervaert og transformeret gaervaert
DE68929115T2 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
ATE334146T1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
ES2171398T3 (es) Acidos nucleicos viricos vegetales recombinantes.
NO904634L (no) Amplifikasjon av nukleinsyre ved anvendelse av ligerbare,haarnaalsprobe og transkripsjon.
ES2150188T3 (es) Procedimiento para la preparacion de una proteina mediante un hongo transformado por integracion multicopia de un vector de expresion.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE3884356D1 (de) Verfahren zur Herstellung von Fremdprotein in Hefe, Rekombinant DNS, Transformant.
IT1303767B1 (it) Metodo di quantificazione di acidi nucleici.
DE3650135D1 (de) Proteingewinnung.
PT96388A (pt) Processo para a obtencao de um promotor artificial para a expressao de proteinas em levedura
BR9811014A (pt) "região concentrada reguladora de gene especìfica para semente precoce"
FI910795A0 (fi) 0-glykocylerad ifg-1.
BR8406644A (pt) Processo para producao de etanol
DE3782560D1 (de) Hefestaemme zur expression fremder gene.
PT93614A (pt) Estirpe de levedura melhorada para a producao de proteinas heterologas maduras,em particular hirudina, e processo para a preparacao da hirudina correspondente
DE68927437D1 (de) Verfahren zur herstellung von luciferase durch rekombinante expression eines luciferase-kodierenden gens
DE3877446D1 (de) Verfahren zur synthese von glutathion in hefen.
DK391185D0 (da) Rekombinant saccharomyces
DE3882455D1 (de) Verfahren zur herstellung von proteinen in loeslicher form.
SE9301583D0 (sv) Yeast strain and methods for expressing heterologous proteins in yeast
ATE139118T1 (de) Ribozymenhemmer
WO1997009430A3 (en) A human metalloproteinase, variants thereof and dna sequences codding therefor
Vorster ASPECTS OF THE ACQUISITION OF AFRIKAANS SYNTAX.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910531

FG3A Patent granted, date of granting

Effective date: 19980327

PC3A Transfer or assignment

Free format text: 20000704 SANOFI-SYNTHELABO FR

PD3A Change of proprietorship

Free format text: SANOFI-AVENTIS FR

Effective date: 20050117

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130327